Vestibulotoxicity as a consequence of systemically administered tobramycin in cystic fibrosis patients (Q46496621)

From Wikidata
Jump to navigation Jump to search
scientific article published in January 2009
edit
Language Label Description Also known as
English
Vestibulotoxicity as a consequence of systemically administered tobramycin in cystic fibrosis patients
scientific article published in January 2009

    Statements

    Vestibulotoxicity as a consequence of systemically administered tobramycin in cystic fibrosis patients (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit